Figure 1

Significant ventricular dilatation and severely reduced global contractile in patient A (LV end-diastolic volume indexed-to-height 224 ml, end systolic volume indexed-to-height 166 ml, ejection fraction 25.8%) who has visibly increased early enhancement (EE ratio 11.2), compared to patient B with lack of early enhancement (EE ratio 2.0) and moderately ventricular function (LV end-diastolic volume indexed-to-height 162 ml, end-systolic volume indexed-to-height 87 ml, ejection fraction 42.5%). Note that both patients have evidence of myocardial fibrosis (arrows).